Neoadjuvant Immunotherapy for Liver Cancer: Shrinking Tumors, Growing Responses
Treating seemingly inoperable liver tumors with neoadjuvant immunotherapy may make surgery more feasible.
Tag: liver cancer
Treating seemingly inoperable liver tumors with neoadjuvant immunotherapy may make surgery more feasible.
As Greek mythology tells us, the titan Prometheus was punished by the gods for giving fire to man. His...
Since the 1990s, the cancer mortality rate in the U.S. has steadily declined. Yet liver cancer death rates in...
Persistent infections from pathogens are a major cause of cancer incidence worldwide. An analysis from 2012 indicates that more...
During the early part of November, we saw the U.S. Food and Drug Administration (FDA) approve a new molecularly...
The past month has seen the U.S. Food and Drug Administration (FDA) expand the use of four anticancer therapeutics,...
Although liver cancer isn’t as prevalent as lung cancer or breast cancer, this cancer is now the fastest-increasing cause...
Last week, the U.S. Food and Drug Administration (FDA) increased the number of types of cancer for which immunotherapeutics...
On Thursday, the U.S. Food and Drug Administration (FDA) expanded the use of the antiangiogenic therapeutic regorafenib (Stivarga) to...
Liver cancer rates have been on the rise in the United States and have tripled in the last four...